Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPIDOTE: Pioglitazone vs Dapagliflozin Add-on in Type 2 Diabetes
NCT03499704Phase 4Completed
- Sponsor
- Celltrion
- Start
- Feb 2020
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Celltrion. Started Feb 2020; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03499704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03499704.